Journal profile · Pharmacology & Pharmacy
ChemMedChem
ISSN 1860-7179 · eISSN 1860-7187 · John Wiley and Sons Ltd · GERMANY · Monthly · Founded 2006
ChemMedChem: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.39; hybrid open access; APC about USD 4,150; median 111 days to acceptance (63 articles, last 24 months); community-reported acceptance: about 75%; 347 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ChemMedChem is published by John Wiley and Sons Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Click Chemistry and Applications and Chemical Synthesis and Analysis, together about 24.1% of its articles. Its main subfields are Organic Chemistry and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
One of the largest and most authoritative collections of online journals, books, and research resources, covering life, health, social, and physical sciences.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science9.3%
- Click Chemistry and ApplicationsChemistry8%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology6.8%
- Synthesis and biological activityChemistry6.7%
- HIV/AIDS drug development and treatmentMedicine5%
- Synthesis and Biological EvaluationChemistry5%
- Peptidase Inhibition and AnalysisMedicine4.7%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.39LetPub ·
- CiteScore 2026-06
- 5.7LetPub ·
- SJR 2026-06
- 0.67LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 92LetPub ·
- h-index
- 123OpenAlex ·
- i10-index
- 3,211OpenAlex ·
- 2-year mean citedness
- 3.01OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 31.05%LetPub ·
Volume
- Articles per year
- 298LetPub ·
Articles by year OpenAlex count · 6,752 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 367 | 239 | 149 |
| 2025 | 347 | 213 | 852 |
| 2024 | 404 | 248 | 2,363 |
| 2023 | 253 | 157 | 2,274 |
| 2022 | 294 | 146 | 3,505 |
| 2021 | 352 | 158 | 5,641 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
111 daysMedian, submission to acceptance · P25–P75 83 days – 133 days
- Acceptance to online
- median 25 days (63 articles)
- Submission to online
- median 135 days
- Sample
- 63 articles with submission and acceptance dates (832 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,720 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Ltd
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 2006
- ISSN
- 1860-7179
- Electronic ISSN
- 1860-7187
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about ChemMedChem
What CAS zone is ChemMedChem in?
In the 2025 upgraded edition of the CAS Journal Ranking, ChemMedChem is in Zone 4 of Medicine, and in Zone 3 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ChemMedChem?
The latest impact factor listed by LetPub is 3.39; CiteScore 5.7, h-index 123.
How long does peer review take at ChemMedChem?
Based on the dates recorded on 63 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 83–133 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ChemMedChem?
According to LetPub and DOAJ records, ChemMedChem is indexed in SCIE and Scopus.
Is ChemMedChem open access, and what is the APC?
ChemMedChem is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .